U.S. Metals and Mining Stock News

Earnings report and 2026 outlook come into focus Assertio Holdings (ASRT) has drawn fresh attention after reporting fourth quarter and full year 2025 results that showed lower revenue, a wider net loss, and new 2026 net product sales guidance of US$110.0 million to US$125.0 million. See our latest analysis for Assertio Holdings. The earnings release and 2026 guidance arrived alongside sharp recent gains, with a 30 day share price return of 63.57% and a 1 year total shareholder return of...

In March 2026, Paysign, Inc. reported fourth-quarter 2025 revenue of US$22.76 million and full-year 2025 revenue of US$82.03 million, alongside 2026 guidance calling for first-quarter revenue of US$27.0–27.5 million, operating margins of 20–22%, and net margins of 17–19%. The company also projected 2026 revenue of US$106.5–110.5 million split roughly evenly between plasma and pharma, with higher gross margins driven by its patient affordability programs and net income guidance of...

Worthington Steel (WS) just posted Q3 2026 results with revenue of US$769.8 million and basic EPS of US$0.21, alongside trailing twelve month revenue of about US$3.3 billion and EPS of US$2.45 that sit against 12.5% earnings growth over the past year versus an average 7.8% annual earnings decline over the past five years. The company has seen quarterly revenue move from US$687.4 million in Q3 2025 to US$832.9 million in Q4 2025, then around US$872.9 million in Q1 2026 and US$871.9 million in...

TeraWulf (NasdaqCM:WULF) has secured a $500 million credit facility led by Morgan Stanley. The financing is earmarked for construction of a new data center in Kentucky. The facility marks a significant expansion of TeraWulf’s digital infrastructure footprint beyond prior projects. TeraWulf, originally known for its bitcoin mining operations, is increasingly positioning its sites for high performance computing and AI hosting. Large scale credit support from a major bank points to...

In recent months, CECO Environmental has delivered strong operational momentum, with annualized revenue growth materially outpacing peers and analysts now projecting further double-digit sales expansion alongside higher adjusted operating margins. This combination of faster growth and improving profitability suggests CECO Environmental may be strengthening its position in the market for air, water, and energy transition solutions. Next, we will explore how CECO Environmental's improving...

How East West Bancorp’s recent share moves frame the valuation question Recent share price moves at East West Bancorp have many investors asking the same question: is the current price offering good value, or is most of the opportunity already reflected in the stock? Over the last week, the stock is up 0.7%, while the past month shows a 7.3% decline and the year-to-date return sits at a 7.8% decline, set against a 19.9% gain over the past year and a 109.5% return over three years. This mix of...

If you are wondering whether Boot Barn Holdings is attractively priced or running ahead of itself, the recent share performance gives you a useful starting point. The stock closed at US$152.83, with returns of 42.5% over 1 year and 104.3% over 3 years, while the past 30 days show a 21.9% decline and the year-to-date return sits at an 18.1% decline. Recent coverage around Boot Barn has focused on its position within specialty retail and how investors are weighing its growth record against...

Wondering whether MGE Energy at around US$75.94 is offering fair value today, or if the price is out of line with the underlying business? This article walks through the key numbers to help you frame that question clearly. The stock has recently moved 2.0% over the last 7 days, while showing an 8.0% decline over 30 days, a 3.2% decline year to date, and a 16.1% decline over the last year, set against gains of 4.7% over 3 years and 18.6% over 5 years. Recent attention around MGE Energy has...

Archrock Inc. (NYSE:AROC) has announced the planned retirement of its long-serving Chief Financial Officer, Douglas S. Aron. The company has begun a formal search process to identify and appoint a new CFO. Aron will continue in his role during the transition period to support continuity in financial leadership. Archrock, a contract compression services provider to the U.S. energy industry, depends heavily on steady capital allocation, balance sheet management and long term contract...

Two XPO (NYSE:XPO) leaders, Chelsey Johnston and Molly Borkgren, have been recognized as "Top Women to Watch in Trucking" by the Women in Trucking Association. The award spotlights their influence and contributions within XPO and the wider transportation sector. This recognition aligns with XPO's ongoing focus on diversity, inclusion, and leadership development across its operations. XPO operates as a major player in freight transportation and logistics, a sector that relies heavily on...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see ReposiTrak...

Cintas, ticker NasdaqGS:CTAS, has agreed to acquire UniFirst in a cash and stock transaction. The deal is set to combine two major players in uniforms and facility services, pending customary approvals. The transaction is designed to expand Cintas reach across customers, service routes, and product offerings. Cintas comes into this planned acquisition with shares at $168.85 and a record of returns over multi year periods. The stock is down 7.1% over the past week, 15.0% over the past month,...

Agilent Technologies, Inc. ( NYSE:A ) is about to trade ex-dividend in the next three days. The ex-dividend date is...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Franklin...

ADMA Biologics (NasdaqGM:ADMA) issued a public response to a short-seller report from Culper Research. The company disputed the accuracy of the allegations and reiterated its focus on regulatory compliance. This exchange centers on claims about ADMA Biologics' business practices and disclosures. For investors, this is notable because ADMA Biologics operates in a tightly regulated biopharmaceutical space where compliance is central to its plasma based therapies business. When a short-seller...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Earnings results and 2026 outlook draw fresh focus to GDS Holdings GDS Holdings (GDS) is back in the spotlight after reporting fourth quarter and full year 2025 results that combined higher revenue with sharply weaker profitability, along with 2026 revenue guidance pointing to further top line expansion. See our latest analysis for GDS Holdings. The share price reaction to the latest earnings and 2026 guidance has been negative in the short term, with a 1 day share price return of a 6.69%...

Wondering if Arcellx at around US$114 per share still offers value, or if the easy money has already been made. The stock has YTD returns of 81.0% and a 1 year return of 68.7%, although the past week has been flat at around a 0.1% decline and the 30 day move sits at 0.8%. Recent coverage has focused on Arcellx as a higher growth biotech name, which helps explain why the share price has been so strong over the past year. That kind of attention often shifts how investors think about both the...

Arlo Technologies recently reported a past quarter in which revenue grew 16.2% year on year, beating analyst forecasts by 4.2% and delivering earnings per share above expectations for both the reported period and its next-quarter guidance. The company also moved from negative to positive full-year earnings per share over the last five years, highlighting a key profitability inflection that builds on its 8.2% annualized revenue growth in the same period. Next, we will examine how Arlo’s...

Intellicheck, Inc. ( NASDAQ:IDN ) recently posted some strong earnings, and the market responded positively. We did...

Why 10x Genomics Is Back in Focus 10x Genomics (TXG) is back on investor watchlists after two catalysts: its role in Bioptimus’ new STELA spatial tissue atlas, and steady share purchases by high profile fund manager Cathie Wood. See our latest analysis for 10x Genomics. The recent partnership on the STELA initiative and continued buying from Cathie Wood have arrived while the share price sits at US$20.43, with a 90 day share price return of 23.89% and a 1 year total shareholder return of...

Over the last 7 days, the United States market has experienced a 1.6% decline, though it remains up by 15% over the past year with earnings projected to grow by 16% annually. In this context, identifying small-cap stocks that are potentially undervalued and exhibit insider action can offer intriguing opportunities for investors seeking to navigate these dynamic market conditions.